Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
USFDA, Aurobindo and Api
Aurobindo Pharma stock drops 4.5% after USFDA flags 10 observations for arm Apitoria's API unit
Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs 1,333, predicting a 12 percent downside.
Aurobindo Pharma's Telangana Facility Receives 10 Observations from USFDA
The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 inspection. The procedural observations will be addressed within the stipulated time.
Aurobindo Pharma shares fall after USFDA issues 10 observations to API unit in Telangana
The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be responded to within the stipulated time.
Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD),
Aurobindo Pharma gets USFDA nod to manufacture Cephalexin tablets
Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.
Daily
10h
USFDA nod to Aurobindo Pharma for Cephalexin Tablets
Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...
ndtvprofit
1d
Aurobindo Pharma Receives US FDA Approval For An Antibiotics Tablet
Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...
1d
Aurobindo Pharma gets U.S. FDA nod for Cephalexin tablets
Aurobindo Pharma receives FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.
4h
Stock Radar: Eicher Motors, Hero MotoCorp, Mankind Pharma, Ashoka Buildcon, KRN Heat, ITC in focus on Thursday
Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...
Daily
13d
Aurobindo Pharma to acquire balance 49 percent stake in GLS Pharma for Rs 22.5 crores
Aurobindo Pharma has announced that the Company has entered into a binding agreement with GLS Pharma Limited, a subsidiary of ...
India Infoline
13d
Aurobindo Pharma to pick up 49% stake in GLS Pharma
Aurobindo
Pharma Ltd announced on Wednesday that it will buy the remaining 49% ownership in GLS Pharma Ltd for ₹22.5 Crore, ...
1d
7 Must Visit Places in Puducherry for an Unforgettable Experience
Paradise Beach, which is well-known for its fine sands and calm waves, provides chances for swimming, boat trips, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Cephalexin
Food and Drug Administration
Feedback